Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-06-14

Clinical Trial Update: The Real-world Firebird 2 Versus Cypher Sirolimus-eluting Stent in Treating Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

A phase 4 real-world trial comparing the Firebird 2 sirolimus-eluting stent to the Cypher sirolimus-eluting stent for coronary artery stenosis has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)
  • Firebird 2 sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Coronary Artery Stenosis | Phase 4 | Status: WITHDRAWN